Aerovate Therapeutics, Inc.·4

Jan 31, 6:00 PM ET

NOYES TIMOTHY P 4

4 · Aerovate Therapeutics, Inc. · Filed Jan 31, 2024

Insider Transaction Report

Form 4
Period: 2024-01-29
NOYES TIMOTHY P
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-29+200,000200,000 total
    Exercise: $18.09Exp: 2034-01-28Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 29, 2024.

Documents

1 file
  • 4
    form4-01312024_060101.xmlPrimary